RESEARCH PAPER
Clinical outcomes and complications of fiberoptic bronchoscopy in HIV-infected patients
 
More details
Hide details
1
Clinical Tuberculosis and Epidemiology Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran
 
2
Tracheal Diseases Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran
 
3
Virology Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran
 
4
Tobacco Prevention and Control Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran
 
 
Submission date: 2020-05-03
 
 
Acceptance date: 2020-05-17
 
 
Publication date: 2020-10-09
 
 
HIV & AIDS Review 2020;19(3):172-179
 
KEYWORDS
TOPICS
ABSTRACT
Introduction:
Respiratory diseases, including infectious and non-infectious complications are common among patients with human immunodeficiency virus (HIV) infection. We aimed to determine the performance of fiberoptic bronchoscopy (FOB), bronchoalveolar lavage, and transbronchial lung biopsy in HIV-infected patients.

Material and methods:
The current retrospective study was performed in Masih Daneshvari Hospital, Tehran, Iran, from January 2003 to March 2017. Patients with HIV infection and 836 episodes of respiratory manifestations were selected. Indications, outcomes as well as results and complications of bronchoscopy were extracted. Performance of bronchoscopy to determine definite etiology and its ability to rule out other differential diagnoses were evaluated.

Results:
The indications of FOB were found in 289 subjects (34.6%) with respiratory diseases, of whom only 220 patients had undergone the procedure. Bronchoscopy confirming a final diagnosis was found in 87 (39.5%) patients and a diagnostic benefit was noted for minimum 66.7% of the subjects. Diagnostic ability of bronchoscopy was higher in patients suspected of pneumocystis jiroveci pneumonia (PJP), tuberculosis (TB), cytomegalovirus (CMV) pneumonitis, and in cases with ground-glass opacity and diffuse lung infiltrates (p-value: 0.003 and 0.035, respectively), and lower for subjects demonstrating reticulonodular infiltrations and right middle and lower lobes involvement (p-value: 0.008, 0.005, and 0.045, respectively). Procedure-related complications were reported in five subjects.

Conclusions:
FOB is a significantly advantageous and safe procedure in HIV-infected patients. Its diag­nostic yield is higher in patients with ground-glass opacity and diffuse infiltration in chest computed tomography scan.

 
REFERENCES (36)
1.
Benito N, Moreno A, Miro JM, Torres A. Pulmonary infections in HIV-infected patients: an update in the 21st century. Eur Respir J 2012; 39: 730-745.
 
2.
Miller R. HIV-associated respiratory diseases. Lancet 1996; 348: 307-312.
 
3.
Danes C, Gonzalez-Martin J, Pumarola T, et al. Pulmonary infiltrates in immunosuppressed patients: analysis of a diagnostic protocol. J Clin Microbiol 2002; 40: 2134-2140.
 
4.
Crawford SW. Noninfectious lung disease in the immunocompromised host. Respiration 1999; 66: 385-395.
 
5.
Du Rand IA, Blaikley J, Booton R, et al. British Thoracic Society guideline for diagnostic flexible bronchoscopy in adults: accredited by NICE. Thorax 2013; 68 Suppl 1: i1-i44.
 
6.
Ikeda S, Yanai N, Ishikawa S. Flexible bronchofiberscope. Keio.
 
7.
J Med 1968; 17: 1-16.
 
8.
Pedersen U, Hansen IM, Bottzauw J. The diagnostic role of fiberoptic bronchoscopy in AIDS patients with suspected Pneumocystis carinii pneumonia. Arch Otorhinolaryngol 1989; 246: 362-364.
 
9.
de Blic J, Blanche S, Danel C, Le Bourgeois M, Caniglia M, Schein­mann P. Bronchoalveolar lavage in HIV infected patients with interstitial pneumonitis. Arch Dis Child 1989; 64: 1246-1250.
 
10.
Griffiths MH, Kocjan G, Miller RF, Godfrey-Faussett P. Diagnosis of pulmonary disease in human immunodeficiency virus infection: role of transbronchial biopsy and bronchoalveolar lavage. Thorax 1989; 44: 554-558.
 
11.
Fischer B, Elmer M, Ramadori G, Lorenz J. HIV-associated infections: indications and importance of fiberoptic bronchoscopy. Pneumologie 1990; 44 Suppl 1: 316-317.
 
12.
Heurlin N, Elvin K, Lidman C, Lidman K, Lundbergh P. Fiberoptic bronchoscopy and sputum examination for diagnosis of pulmonary disease in AIDS patients in Stockholm. Scand J Infect Dis 1990; 22: 659-664.
 
13.
Kennedy DJ, Lewis WP, Barnes PF. Yield of bronchoscopy for the diagnosis of tuberculosis in patients with human immunodeficiency virus infection. Chest 1992; 102: 1040-1044.
 
14.
Henriquez A, Srur E, Giglio M, et al. Etiologic diagnosis of pneumonia in HIV-AIDS patients. Usefulness of fibrobronchoscopy. Rev Med Chil 1993; 121: 279-285.
 
15.
Steiner S, Schwalen A, Klein RM, et al. Results and complications of fiber bronchoscopy in HIV positive patients. Pneumologie 1998; 52: 694-699.
 
16.
Ghosn J, Taiwo B, Seedat S, Autran B, Katlama C. HIV. Lancet 2018; 392: 685-697.
 
17.
van der Eerden MM, Vlaspolder F, de Graaff CS, Groot T, Jansen HM, Boersma WG. Value of intensive diagnostic microbiological investigation in low- and high-risk patients with community-acquired pneumonia. Eur J Clin Microbiol Infect Dis 2005; 24: 241-249.
 
18.
Griffith DE, Aksamit T, Brown-Elliott BA, et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med 2007; 175: 367-416.
 
19.
Worodria W, Davis JL, Cattamanchi A, et al. Bronchoscopy is useful for diagnosing smear-negative tuberculosis in HIV-infected patients. Eur Respir J 2010; 36: 446-448.
 
20.
Supervia Caparros A, Minguez Maso S, Galofre Alvaro N, Knobel Freud H, Currull Serrano V, Sanjuás Benito C. Fiber optics bronchoscopy yield and predictive clinical, analytical, and radiologic factors in the etiologic diagnosis of pulmonary pathology in patients with HIV infection. An Med Interna 1993; 10: 532-536.
 
21.
Baughman RP, Dohn MN, Frame PT. The continuing utility of bronchoalveolar lavage to diagnose opportunistic infection in AIDS patients. Am J Med 1994; 97: 515-522.
 
22.
O’Donnell WJ, Pieciak W, Chertow GM, Sanabria J, Lahive KC. Clearance of Pneumocystis carinii cysts in acute P. carinii pneumonia: assessment by serial sputum induction. Chest 1998; 114: 1264-1268.
 
23.
Fecci L, Consigli GF. Bronchoscopy in intensive care unit. Monaldi Arch Chest Dis 2011; 75: 67-71.
 
24.
Huang L, Hecht FM, Stansell JD, Montanti R, Hadley WK, Hope-.
 
25.
well PC. Suspected Pneumocystis carinii pneumonia with a negative induced sputum examination. Is early bronchoscopy useful? Am.
 
26.
J Respir Crit Care Med 1995; 151: 1866-1871.
 
27.
Huang L, Cattamanchi A, Davis JL, et al. HIV-associated Pneumocystis pneumonia. Proc Am Thorac Soc 2011; 8: 294-300.
 
28.
Santoso P, Soeroto AY, Juniati R, et al. Improving diagnostic of pulmonary tuberculosis in HIV patients by bronchoscopy: a cross sectional study. Acta Med Indones 2017; 49: 330-335.
 
29.
Salzman SH, Schindel ML, Aranda CP, Smith RL, Lewis ML. The role of bronchoscopy in the diagnosis of pulmonary tuberculosis in patients at risk for HIV infection. Chest 1992; 102: 143-146.
 
30.
Coker RJ, Mitchell DM. The role of bronchoscopy in patients with HIV disease. Int J STD AIDS 1994; 5: 172-176.
 
31.
Orenstein M, Webber CA, Cash M, Heurich AE. Value of bronchoalveolar lavage in the diagnosis of pulmonary infection in acquired immune deficiency syndrome. Thorax 1986; 41: 345-349.
 
32.
Milligan SA, Luce JM, Golden J, Stulbarg M, Hopewell PC. Transbronchial biopsy without fluoroscopy in patients with diffuse roentgenographic infiltrates and the acquired immunodeficiency syndrome. Am Rev Respir Dis 1988; 137: 486-488.
 
33.
Simpson FG, Arnold AG, Purvis A, Belfield PW, Muers MF, Cooke NJ. Postal survey of bronchoscopic practice by physicians in the United Kingdom. Thorax 1986; 41: 311-317.
 
34.
Cazzadori A, Di Perri G, Todeschini G, et al. Transbronchial biopsy in the diagnosis of pulmonary infiltrates in immunocompromised patients. Chest 1995; 107: 101-106.
 
35.
Malekmohammad M, Marjani M, Tabarsi P, et al. Diagnostic yield of post-bronchoscopy sputum smear in pulmonary tuberculosis. Scand J Infect Dis 2012; 44: 369-373.
 
36.
George PM, Mehta M, Dhariwal J, et al. Post-bronchoscopy sputum: improving the diagnostic yield in smear negative pulmonary TB. Respir Med 2011; 105: 1726-1731.
 
eISSN:1732-2707
ISSN:1730-1270
Journals System - logo
Scroll to top